Data offers hope as winter looms in north and raises viability of eliminating future flu pandemics
DALLAS – Sept. 17, 2020 – When used to manage infections, the drug itraconazole is generally given at a single, fixed dose to all patients. But...
Lugano, Switzerland, 18 September 2020 – Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to...
New research on the Gympie-Gympie tree has revealed a new type of venom that could teach us more about how our bodies respond to pain.
In a study published on the bioRxiv preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of...
Scientists at St. Jude Children's Research Hospital have identified the structure of double-strand DNA break repair by PARP enzymes. The findings show that PARP2 can bridge...
A recent study documents how personal risk assessment and protective behaviors are linked.
A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of...
The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s AZN.L COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to...
Intracranial abnormalities on CT scan in patients with traumatic brain injury (TBI) can be predicted by glial fibrillary acidic protein (GFAP) levels in the blood.